IJCS | Volume 33, Nº3, May / June 2020

223 1. Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, et al; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics—2015: update a report from the American Heart Association. Circulation. 2015;131(4):e29-e322. 2. Scala LC, Magalhães LB, Machado A. Epidemiologia da hipertensão arterial sistêmica. In: Moreira SM, Paola AV; Sociedade Brasileira de Cardiologia. Livro Texto da Sociedade Brasileira de Cardiologia. 2ª. ed. São Pauilo: Manole; 2015. p. 780-5. 3. Brasil. Ministério da Saúde. Estratégias para o cuidado da pessoa com doença crônica: hipertensão arterial sistêmica. Brasília: Ministério da Saúde, 2013. (Cadernos de Atenção Básica, n. 37). 4. ReisAPA, Pimenta TR, Rossi VEC, MaiaMAC,Andrade RD. Hipertensão Arterial e Diabetes Mellitus: sistematização da assistência através da consulta de enfermagem emuma Unidade Escola do Programa de Saúde da Família. Ciência et Praxis. 2014; 7(13): 55-62. 5. PimentaHB, CaldeiraAP. Cardiovascular risk factors on the Framingham Risk Score among hypertensive patients attended by family health teams. Ciênc. saúde coletiva. 2014 Jun; 19( 6 ): 1731-1739. 6. Cichocki M, Fernandes KP, Castro-Alves DC, Gomes MVM. Physical activity and modulation of cardiovascular risk. Rev Bras Med Esporte. 2017 Fev; 23(1): 21-25. 7. SBC. Sociedade Brasileira de Cardiologia. Departamento de Hipertensão Arterial. VII Diretrizes brasileiras de hipertensão. Rev Bras Hipertens. 2016;107(3)supl3:1-103. 8. Matsudo S, Araújo T, Matsudo V, Andrade D, Andrade E, Oliveira L, Braggion G. Questionário Internacional De Atividade Física (IPAQ): Estudo de validade e reprodutibilidade no Brasil. Rev Bras Ativ Saude. 15out.2012;6(2):5-8. 9. Jelliffe DBI. Evaluación del estado de nutrición de la comunidad. Genebra: OMS; 1968. 10. World Health Organization.(WHO). Obesity: Preventing andmanaging the global epidemic. Report of a WHO Consulation on Obesity. Geneva; 2000. 11. Lipschitz DA. Screening for nutritional status in the elderly. Prim Care, v. 21, n.1, p. 55-67, 1994. 12. KDIGO. Kidney Disease Improving Global Outcomes. CKD Work Group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl.2013;3(1):1-150. 13. Girman CJ, Rhodes T, Mercuri M, Pyörälä K, Kjeshus J, Pedersen TR, et al. The metabolic syndrome and risk of major coronary events in the Scandinavian Simvastatin Survival Study (4S) and the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS). Am J Cardiol. 2004;93:136-41. 14. Brasil. Ministério da Saúde. Secretaria de Vigilância em Saúde. Departamento de Vigilância de Doenças e Agravos não Transmissíveis e Promoção da Saúde. Vigitel Brasil 2016: vigilância de fatores de risco e proteção para doenças crônicas por inquérito telefônico: estimativas sobre frequência e distribuição sociodemográfica de fatores de risco e proteção para doenças crônicas nas capitais dos 26 estados brasileiros e no Distrito Federal em 2016. Brasília;2017. 15. Malta DC, Bernal RTI,Andrade SSCA, SilvaMMA, Velasquez-Melendez G. Prevalence of and factors associated with self-reported high blood pressure in Brazilian adults. Rev Saúde Pública. 2017; 51( Suppl 1 ): 1-11. References Moreira et al. Cardiovascular risk in hypertensive individuals Int J Cardiovasc Sci. 2020; 33(3):217-224 Original Article included with more emphasis on the agenda of services of PCH teams. These findings reinforce the importance of continuous and longitudinal health practices directed to the male population, focusing on the reduction of CVR. In addition, new studies correlating the lifestyle and health behaviors with CVR factors in different regional and care contexts are needed, to justify the development of effective public policies. Finally, this study stresses out the potential of the FRS as a tool for stratifying the CVR in hypertensive patients attending PHC centers, aiming at improving the management and promoting high-quality care to these paients. Author contributions Conception and design of the research: Moreira TR, Silva LS, Cotta RMM. Acquisition of data: Silva LS. Analysis and interpretation of the data: Moreira TR, Toledo LV, Mendonça ET. Statistical analysis: Moreira TR. Writing of the manuscript: Toledo LV, Mendonça ET, Colodette RM. Critical revision of the manuscript for intellectual content: Moreira TR, Colodette RM, Silva LS, Cotta RMM. Potential Conflict of Interest No potential conflict of interest relevant to this article was reported. Sources of Funding There were no external funding sources for this study. Study Association This study is not associated with any thesis or dissertation work. Ethics approval and consent to participate This study was approved by the Ethics Committee of the Universidade Federal de Viçosa under the protocol number 044/2012. All the procedures in this study were in accordance with the 1975 Helsinki Declaration, updated in 2013. Informed consent was obtained from all participants included in the study.